Sunlit IVS: Financial statements 2019
CVR: 37667269
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Sunlit IVS (CVR 37667269) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 69,614 and a net result of DKK 29,125 compared with DKK -78,874 the year before. That is an increase of 8,601.8% compared with the year before. The profit margin was 41.8%. Equity in the 2019 report amounted to DKK 118,527. The solvency ratio was 59.3%.
- Revenue
- DKK 69,614
- Gross Profit
- DKK 43,669
- Profit/Loss
- DKK 29,125
- Equity
- DKK 118,527
- Total Assets
- DKK 199,968
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 70 t. | 44 t. | 29 t. | 119 t. | - |
| 2018 | 800 | -79 t. | -79 t. | 39 t. | - |
| 2017 | 5 t. | -106 t. | -83 t. | 43 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
On September 19, 2019, the company changed its name from NuBiotrient IVS to Sunlit IVS.
Sunlit IVS has published its annual report for 2018. Revenue came to DKK 800, and the net result was DKK -78,874.
About Sunlit IVS
Sunlit IVS was a Danish company of the type Iværksætterselskab based in Skævinge, founded in 2016. The company has been dissolved on 14 December 2020. The company was registered under the industry Industriel design og produktdesign. The company was previously named NuBiotrient IVS. In 2019, the company reported revenue of DKK 69,614 and a net result of DKK 29,125 compared with DKK -78,874 the year before. Equity in the 2019 report amounted to DKK 118,527.